137 related articles for article (PubMed ID: 7772533)
1. Correction of anaemia and thrombocytopenia in a case of adult type I osteopetrosis with recombinant human erythropoietin (rHuEPO).
Meletis J; Samarkos M; Michali E; Vavourakis S; Meletis C; Poziopoulos C; Stavrogianni N; Konstantopoulos K; Vaiopoulos G; Yataganas X
Br J Haematol; 1995 Apr; 89(4):911-3. PubMed ID: 7772533
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation.
Ayash LJ; Elias A; Hunt M; Demetri G; Wheeler C; Tepler I; Schwartz G; Mazanet R; Reich E; McCauley M
Br J Haematol; 1994 May; 87(1):153-61. PubMed ID: 7947240
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia.
Ponchio L; Beguin Y; Farina G; Pedrazzoli P; Pedrotti C; Poggi G; Rosti V; Bergamaschi G; Battistel V; Cazzola M
Haematologica; 1992; 77(6):494-501. PubMed ID: 1289186
[TBL] [Abstract][Full Text] [Related]
4. [Recombinant erythropoietin--a fundamental change in the treatment of anemia?].
Sasinka M; Podracká L; Roland R
Cesk Pediatr; 1992 Apr; 47(4):220-5. PubMed ID: 1628358
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin may correct erythropoietin-deficient hyporegenerative anaemia in children given cardiac transplantation.
Locatelli F; Zecca M; Mamprin F; Gamba A; Giorgiani G; De Stefano P
Br J Haematol; 1994 Nov; 88(3):623-5. PubMed ID: 7819078
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of recombinant human erythropoietin (rhuEPO) in treatment of anemia in patients with myelodysplastic syndrome].
Wiecek A; Chudek J; Nieszporek T; Kokot F
Pol Arch Med Wewn; 1992 Dec; 88(6):451-7. PubMed ID: 1300567
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin is effective in correcting erythropoietin-deficient anaemia after allogeneic bone marrow transplantation.
Locatelli F; Pedrazzoli P; Barosi G; Zecca M; Porta F; Liberato L; Gambarana D; Nespoli L; Cazzola M
Br J Haematol; 1992 Apr; 80(4):545-9. PubMed ID: 1581240
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of multiple myeloma associated anemia with human recombinant erythropoietin in a hemodialysis patient].
Muszytowski M; Nowak J; Wojnicz M; Zalewska A; Ruszkiewicz-Fołda M
Pol Arch Med Wewn; 1995 Jan; 93(1):77-9. PubMed ID: 7479222
[TBL] [Abstract][Full Text] [Related]
9. The use of recombinant human erythropoietin (rHuEpo) in humans.
Adamson JW; Eschbach JW
Cancer Surv; 1990; 9(1):157-67. PubMed ID: 2276112
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
Henry DH; Abels RI
Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
[TBL] [Abstract][Full Text] [Related]
11. [Malignant infantile osteopetrosis revealed by choanal atresia: A case report].
Ba ID; Ba A; Thiongane A; Ly/Ba A; Ba M; Fattah M; Faye PM; Cissé DF; Diouf FN
Arch Pediatr; 2016 May; 23(5):514-8. PubMed ID: 27017359
[TBL] [Abstract][Full Text] [Related]
12. Renal risk-benefit determinants of recombinant human erythropoietin therapy in the remnant kidney rat model - hypertension, anaemia, inflammation and drug dose.
Ribeiro S; Garrido P; Fernandes J; Vala H; Rocha-Pereira P; Costa E; Belo L; Reis F; Santos-Silva A
Clin Exp Pharmacol Physiol; 2016 Mar; 43(3):343-54. PubMed ID: 26889660
[TBL] [Abstract][Full Text] [Related]
13. [The role of human recombinant erythropoietin in oncologic surgery].
Mercuriali F
Tumori; 1997; 83(4 Suppl 2):S16-9. PubMed ID: 9487379
[TBL] [Abstract][Full Text] [Related]
14. [Remarkable improvement of anemia by administration of recombinant human erythropoietin in a patient with aplastic anemia].
Misago M; Mori N; Hoshuyama T; Tsukada J; Morimoto I; Oda S; Chiba S; Eto S
Rinsho Ketsueki; 1991 Aug; 32(8):912-4. PubMed ID: 1942534
[TBL] [Abstract][Full Text] [Related]
15. Non-erythropoietin-based anaemia management in chronic kidney disease.
Hörl WH
Nephrol Dial Transplant; 2002; 17 Suppl 11():35-8. PubMed ID: 12386256
[TBL] [Abstract][Full Text] [Related]
16. Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants.
Locatelli F; Zecca M; Pedrazzoli P; Prete L; Quaglini S; Comoli P; De Stefano P; Beguin Y; Robustelli della Cuna G; Severi F
Bone Marrow Transplant; 1994 Apr; 13(4):403-10. PubMed ID: 8019464
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of erythropoiesis in haemodialysis patients demonstrates gradual expansion of erythroblasts during constant treatment with recombinant human erythropoietin.
Beguin Y; Loo M; R'Zik S; Sautois B; Lejeune F; Rorive G; Fillet G
Br J Haematol; 1995 Jan; 89(1):17-23. PubMed ID: 7833259
[TBL] [Abstract][Full Text] [Related]
18. Pediatric uses of recombinant human erythropoietin: the outlook in 1991.
Alexander SR
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):42-53. PubMed ID: 1928079
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow amyloidosis with erythropoietin-resistant anemia in a patient undergoing chronic hemodialysis treatment.
Cetinkaya R; Odabas AR; Selcuk Y; Erman Z; Kaya H
South Med J; 2003 May; 96(5):491-3. PubMed ID: 12911189
[TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant human erythropoietin (rHuEPO) on nutritional status of hemodialysis patients: investigation of direct anabolic effects of rHuEPO.
Usuba T; Kuno T; Higuchi T; Kikuchi F; Nagura Y; Kanmatsuse K; Takahashi S
Nihon Jinzo Gakkai Shi; 1994 Nov; 36(11):1288-95. PubMed ID: 7853762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
